- Joined
- Nov 28, 2000
- Messages
- 524
Hello.
A friend of mine has been diagnosed with early stage breast cancer. Now, after her surgery, her doctors are suggesting that in addition to her standard treatment, she should also participate in a clinicla trial. The cancer has spread to 7 lymph nodes. Does anyone have experience with clinical trials, esp. those related to cancer? She is considering one of them, but also doesn't exactly like the idea of being a guinea pig. Standard chemo treatment is difficult enough already.
:thumbdn:
The standard treatment consists of doxorubicin, cyclophosphamide and docetaxel. The clinical test is divided into three groups. The first group receives the standard treatment listed above. The second group receives paclitaxel along with the standard treament. The third group receives paclitaxel and gemcitabine, along with the standard treament.
The first group [standard treatment only] is administered treatment once every three weeks, for a total of six visits over an eighteen week period.
The second group receives their treatment once every two weeks, for a total of four visits. However, the dosages administered are higher than the standard treatment. Then, the paclitaxel [175 mg/m2] is given for four additional visits, once every two weeks.
The third group receives their treatment just as the second group, but with the addition of gemcitabine. Then, the paclitaxel and gemcitabine is given for four additional visits, once every two weeks.
Thanks for your help,
Frank
A friend of mine has been diagnosed with early stage breast cancer. Now, after her surgery, her doctors are suggesting that in addition to her standard treatment, she should also participate in a clinicla trial. The cancer has spread to 7 lymph nodes. Does anyone have experience with clinical trials, esp. those related to cancer? She is considering one of them, but also doesn't exactly like the idea of being a guinea pig. Standard chemo treatment is difficult enough already.


The standard treatment consists of doxorubicin, cyclophosphamide and docetaxel. The clinical test is divided into three groups. The first group receives the standard treatment listed above. The second group receives paclitaxel along with the standard treament. The third group receives paclitaxel and gemcitabine, along with the standard treament.
The first group [standard treatment only] is administered treatment once every three weeks, for a total of six visits over an eighteen week period.
The second group receives their treatment once every two weeks, for a total of four visits. However, the dosages administered are higher than the standard treatment. Then, the paclitaxel [175 mg/m2] is given for four additional visits, once every two weeks.
The third group receives their treatment just as the second group, but with the addition of gemcitabine. Then, the paclitaxel and gemcitabine is given for four additional visits, once every two weeks.
Thanks for your help,
Frank